BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
31 results:

  • 1. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
    Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
    BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
    Nakamura A; Yamaguchi O; Mori K; Miura K; Tamiya M; Oba T; Yanagitani N; Mizutani H; Ninomiya T; Kajiwara T; Ito K; Miyanaga A; Arai D; Kodama H; Kobayashi K; Kaira K
    Eur J Cancer; 2023 May; 184():62-72. PubMed ID: 36905770
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multi-Omics Immune Interaction Networks in lung cancer Tumorigenesis, Proliferation, and Survival.
    Ye Q; Hickey J; Summers K; Falatovich B; Gencheva M; Eubank TD; Ivanov AV; Guo NL
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499305
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cediranib Induces Apoptosis, G1 Phase Cell Cycle Arrest, and Autophagy in Non-Small-Cell lung cancer Cell A549 In Vitro.
    Guo M; Liu Z; Si J; Zhang J; Zhao J; Guo Z; Xie Y; Zhang H; Gan L
    Biomed Res Int; 2021; 2021():5582648. PubMed ID: 33860036
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Myopericytoma arising from myopericytosis-a hitherto unrecognized entity within the lung.
    Gruber-Moesenbacher U; Morresi-Hauff A; Behr K; Popper H
    Virchows Arch; 2021 May; 478(5):841-849. PubMed ID: 33244708
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma.
    Roussel E; Verbiest A; Milenkovic U; Van Cleynenbreugel B; Van Poppel H; Joniau S; Beuselinck B; Albersen M
    Scand J Urol; 2020 Dec; 54(6):493-499. PubMed ID: 32924729
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing.
    Zhao Y; He JY; Cui JZ; Meng ZQ; Zou YL; Guo XS; Chen X; Wang X; Yan LT; Han WX; Li C; Guo L; Bu H
    BMC Cancer; 2020 Jul; 20(1):690. PubMed ID: 32711494
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses.
    Zhao B; Wang Y; Wang Y; Chen W; Zhou L; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    Aging (Albany NY); 2020 Jul; 12(14):14244-14270. PubMed ID: 32669477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
    Zhao H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Intervention of Vascular Dysplasia Caused by Different Mechanisms - Anlotinib for Right lung Squamous Cell Carcinoma Combined with Thromboangiitis Obliterans: A Case Report and Literature Review].
    Hao H; Zhang M; Zhang G; Zhu H; Bao W
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):60-64. PubMed ID: 31948540
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Renal Cell Carcinoma With Extensive Tumor Thrombus Into the Inferior Vena Cava and Right Atrium in a 70-Year-Old Man.
    Oltean MA; Matuz R; Sitar-Taut A; Mihailov A; Rednic N; Tantau A; Toganel R; Minciuna IA; Orasan O; Muresan F; Cozma A
    Am J Mens Health; 2019; 13(3):1557988319846404. PubMed ID: 31046582
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of lung Adenocarcinoma.
    Tian W; Li YS; Zhang JH; Li JJ; Gao JH
    DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.
    Zhao J; Zhang X; Gong C; Zhang J
    Medicine (Baltimore); 2017 Dec; 96(50):e9259. PubMed ID: 29390367
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Preliminary study of exon sequence in pneumoconiosis and pneumoconiosis complicated with lung cancer using high-throughput sequencing technology].
    Jiang MF; Li L; Wang Z; Zhang CL; Zhang H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Nov; 35(11):801-806. PubMed ID: 29316748
    [No Abstract]    [Full Text] [Related]  

  • 17. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
    Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD
    BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
    Masago K; Fujita S; Muraki M; Hata A; Okuda C; Otsuka K; Kaji R; Takeshita J; Kato R; Katakami N; Hirata Y
    BMC Cancer; 2015 Nov; 15():908. PubMed ID: 26572169
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell lung cancer.
    Wang Y; Huang L; Wu S; Jia Y; Yang Y; Luo L; Bi A; Fang M
    PLoS One; 2015; 10(9):e0139285. PubMed ID: 26422603
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer.
    Liu KJ; Ding LY; Wu HY
    Tumour Biol; 2015 Mar; 36(3):1323-7. PubMed ID: 25731729
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.